These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

58 related items for PubMed ID: 11871317

  • 1. [Efflux pumps of gram-positive bacteria and resistance to fluoroquionolones].
    Egorov AM, Sazykin IuO.
    Antibiot Khimioter; 2001; 46(8):3-5. PubMed ID: 11871317
    [No Abstract] [Full Text] [Related]

  • 2. Efflux-mediated resistance to fluoroquinolones in gram-positive bacteria and the mycobacteria.
    Poole K.
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2595-9. PubMed ID: 10991829
    [No Abstract] [Full Text] [Related]

  • 3. Effectiveness of fluoroquinolones against gram-positive bacteria.
    Bush K, Goldschmidt R.
    Curr Opin Investig Drugs; 2000 Sep; 1(1):22-30. PubMed ID: 11249591
    [Abstract] [Full Text] [Related]

  • 4. Fluoroquinolone antibacterials: SAR mechanism of action, resistance, and clinical aspects.
    Gootz TD, Brighty KE.
    Med Res Rev; 1996 Sep; 16(5):433-86. PubMed ID: 8865150
    [No Abstract] [Full Text] [Related]

  • 5. In vitro and bactericidal activities of ABT-492, a novel fluoroquinolone, against Gram-positive and Gram-negative organisms.
    Almer LS, Hoffrage JB, Keller EL, Flamm RK, Shortridge VD.
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2771-7. PubMed ID: 15215148
    [Abstract] [Full Text] [Related]

  • 6. In vitro activity of E-3846, a new fluoroquinolone, against gram-negative and gram-positive bacteria.
    Moros M, Coll R, Esteve M, Parés J, Xicota MA.
    Chemioterapia; 1987 Jun; 6(2 Suppl):149-51. PubMed ID: 3509373
    [No Abstract] [Full Text] [Related]

  • 7. The quinolones.
    Neu HC.
    Infect Dis Clin North Am; 1989 Sep; 3(3):625-39. PubMed ID: 2671143
    [Abstract] [Full Text] [Related]

  • 8. [New fluoroquinolones and treatment of acute sinusitis].
    Gehanno P, Trémolières F.
    Presse Med; 1999 Sep 04; 28(25):1365. PubMed ID: 10506868
    [No Abstract] [Full Text] [Related]

  • 9. Antimicrobial activity of fluoroquinolones and other antibiotics on 1,116 clinical gram-positive and gram-negative isolates.
    Mascellino MT, Farinelli S, Iegri F, Iona E, De Simone C.
    Drugs Exp Clin Res; 1998 Sep 04; 24(3):139-51. PubMed ID: 9825230
    [Abstract] [Full Text] [Related]

  • 10. In vitro ciprofloxacin resistance patterns of gram-positive bacteria isolated from clinical specimens in a teaching hospital in Saudi Arabia.
    Akhtar N, Alzahrani A, Obeid Oel-T, Dassal D.
    J Ayub Med Coll Abbottabad; 2009 Sep 04; 21(3):54-6. PubMed ID: 20929013
    [Abstract] [Full Text] [Related]

  • 11. Comparative bactericidal activity of fluoroquinolones against clinical isolates resistant to fluoroquinolones.
    Drago L, De Vecchi E, Nicola L, Valli M, Marchetti F, Gismondo MR.
    J Chemother; 2003 Apr 04; 15(2):118-23. PubMed ID: 12797386
    [Abstract] [Full Text] [Related]

  • 12. [The difluoroquinolone lomefloxacin--an broad spectrum antimicrobial drug].
    Padeĭskaia EN, Iakovlev VP.
    Antibiot Khimioter; 1998 Apr 04; 43(2):30-9. PubMed ID: 9551171
    [No Abstract] [Full Text] [Related]

  • 13. [Moxifloxacin--antimicrobial activity and pharmacokinetic properties].
    Iakovlev VP, Polushkina NR.
    Antibiot Khimioter; 2002 Apr 04; 47(5):19-29. PubMed ID: 12365324
    [No Abstract] [Full Text] [Related]

  • 14. In vitro and in vivo antibacterial activities of DW-224a, a new fluoronaphthyridone.
    Park HS, Kim HJ, Seol MJ, Choi DR, Choi EC, Kwak JH.
    Antimicrob Agents Chemother; 2006 Jun 04; 50(6):2261-4. PubMed ID: 16723601
    [Abstract] [Full Text] [Related]

  • 15. Overview of the fluoroquinolone antibiotics.
    Just PM.
    Pharmacotherapy; 1993 Jun 04; 13(2 Pt 2):4S-17S. PubMed ID: 8386356
    [Abstract] [Full Text] [Related]

  • 16. [Trovafloxacin].
    Azanza JR, Ollero D, Sádaba B, García Quetglas E.
    Rev Med Univ Navarra; 1999 Jun 04; 43(1):45-57. PubMed ID: 10386346
    [No Abstract] [Full Text] [Related]

  • 17. Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacin.
    Barry AL, Fuchs PC.
    J Chemother; 1997 Feb 04; 9(1):9-16. PubMed ID: 9106012
    [Abstract] [Full Text] [Related]

  • 18. [The possibility of drug design of quinolones effective for multiresistant gram-positive pathogens].
    Hayakawa I.
    Nihon Rinsho; 1997 May 04; 55(5):1266-71. PubMed ID: 9155185
    [Abstract] [Full Text] [Related]

  • 19. [New fluoroquinolones: characteristics of antimicrobial effect and pharmacokinetics].
    Bondareva NS, Budanov SV.
    Antibiot Khimioter; 1998 May 04; 43(8):28-33. PubMed ID: 9777103
    [No Abstract] [Full Text] [Related]

  • 20. In vitro antibacterial activity of DX-619, a novel des-fluoro(6) quinolone.
    Fujikawa K, Chiba M, Tanaka M, Sato K.
    Antimicrob Agents Chemother; 2005 Jul 04; 49(7):3040-5. PubMed ID: 15980395
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.